UBS Group AG lowered its holdings in Sotera Health Company (NASDAQ:SHC – Free Report) by 13.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 441,511 shares of the company’s stock after selling 67,754 shares during the quarter. UBS Group AG owned approximately 0.16% of Sotera Health worth $7,788,000 at the end of the most recent reporting period.
Several other hedge funds have also recently modified their holdings of SHC. Empowered Funds LLC increased its holdings in Sotera Health by 11.1% during the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock valued at $332,000 after buying an additional 2,845 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Sotera Health by 14.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock worth $3,999,000 after buying an additional 43,471 shares in the last quarter. Acadian Asset Management LLC lifted its holdings in Sotera Health by 125.5% during the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock worth $293,000 after buying an additional 14,018 shares during the period. Creative Planning lifted its holdings in Sotera Health by 15.3% during the second quarter. Creative Planning now owns 20,186 shares of the company’s stock worth $224,000 after buying an additional 2,673 shares during the period. Finally, Invesco Ltd. boosted its position in Sotera Health by 4.2% during the 2nd quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock valued at $3,549,000 after acquiring an additional 12,758 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.
Sotera Health Trading Up 0.5%
Shares of Sotera Health stock opened at $15.35 on Tuesday. The firm’s 50 day simple moving average is $14.88 and its two-hundred day simple moving average is $16.42. The firm has a market capitalization of $4.38 billion, a price-to-earnings ratio of 37.44 and a beta of 1.82. Sotera Health Company has a 12-month low of $10.80 and a 12-month high of $19.85. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56.
Insiders Place Their Bets
In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 15.36% of the company’s stock.
Analysts Set New Price Targets
Several research firms have recently commented on SHC. Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Piper Sandler reaffirmed an “overweight” rating and set a $22.00 price objective (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Barclays cut their target price on Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Citigroup increased their price target on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Tuesday, February 24th. Finally, Zacks Research downgraded Sotera Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 30th. Seven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Sotera Health has a consensus rating of “Moderate Buy” and a consensus target price of $20.33.
Get Our Latest Stock Analysis on Sotera Health
Sotera Health Company Profile
Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.
Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.
Featured Stories
- Five stocks we like better than Sotera Health
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.
